Target intelligence / Profile preview

G protein-coupled receptor 161 (GPR161)

Target
GPR161
Molecular classification
G protein-coupled receptor, Receptor, Orphan GPCR, Rhodopsin-like receptor (Class A)
01

Overview

G protein-coupled receptor 161 (GPR161) is an orphan G protein-coupled receptor broadly classified within the Class A (Rhodopsin-like) receptor family[1][4]. It is primarily localized to primary cilia, where it functions as a key negative regulator of Hedgehog (Hh) signaling, chiefly by promoting cAMP-dependent protein kinase A (PKA) activation. Elevated cAMP via GPR161 suppresses Hh pathway activation by stimulating the conversion of GLI transcription factors into their repressor forms, critical for proper neural tube and organ development[1][3][4]. Constitutively active due to unique self-activation via its extracellular loop and possibly sterol interaction, GPR161 is essential for neural fold apposition and lens, CNS, and limb development. Overexpression has been linked to cancer, especially in subtypes such as triple-negative breast cancer[4]. No endogenous ligand has been confirmed, but the receptor presents a potential druggable site in its extrahelical sterol-binding pocket[1]. Inhibition or loss of GPR161 function leads to inappropriate Hh pathway activation, with implications for developmental disorders and malignancy[1][2][4].

Other names
GPR161RE2G-protein coupled receptor RE2G-protein coupled receptor 161
02

Mechanism of action

Modulation of cAMP signaling via G_s protein coupling; Regulation of protein kinase A (PKA) activity in primary cilia; Negative regulation of Hedgehog signaling through GLI repression

03

Biological functions

Signal transductionRegulation of cellular cAMP levelsSuppression of Hedgehog pathway signalingRegulation of embryonic developmentRegulation of GLI transcription factor processing
04

Disease associations

Cancer (notably triple-negative breast cancer)MedulloblastomaNeural tube development disordersPituitary stalk interruption syndrome
05

Safety considerations

Potential for unintended Hedgehog pathway modulation, which could disrupt developmental or proliferative processesPossible effects on embryonic development and neural tube closure if targeted in utero
06

Biomarkers

Overexpression in triple-negative breast cancerExpression in neural fold/lens during embryonic development

Beyond the preview

Go deeper on G protein-coupled receptor 161 (GPR161).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 161 (GPR161).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call